Saturday, June 10, 2006 7:22:36 AM
"Iplex is also being investigated for various other indications including extreme insulin resistance, myotonic muscular dystrophy and HIV Associated Adipose Redistribution Syndrome."
This alludes to "various other indications" but the ones mentioned sound fairly obscure compared to muscle wasting conditions, hip fractures, osteoporosis, and severe burns. I am certainly leaving out other catabolic states of which I am unaware.
Aren't there ongoing investigations into these conditions? Haven't there already been studies which prove efficacy in these conditions even if the studies were not official Phase ! or !! trials?
My point is obvious. If more common conditions had been mentioned explicitly that might have prompted more attention and perhaps more buying of the stock than obscure ones which do not generate recognition in the public's mind.
BTW WGAT and INSM are presently priced about the same. Don't you have a loved one, a relative or friend, or a business associate, whom you would want to be able to SEE when you speak to each other on the telephone. The Ojo and the Shadow Ojo are least expensive at 101phones.com (search ojo) after $150 rebate good until end of June.
UNLIMITED VIDEO PHONE CALLS WORLDWIDE FOR LOW FLAT MONTHLY FEE OVER BROADBAND CABLE OR DSL. see it at www.wgate.com 14.95 if paid monthly, or 164 per year if paid annually which amts to 13.50 per month.
Advertisement brought to you as a public service announcement by a fellow INSM shareholder. In addition to this message board you guys and gals could have a back channel means of communication with Ojo video telephones just like the WGAT shareholders do and still post here. You can register the Ojo with your present phone number.
Attach your modem to a wall outlet with an ethernet cable and plug another cable to your Ojo or Shadow Ojo and use it connected to any other wall outlet in your home or on the deck, the porch or out by the pool, with no degradation of the picture. Did I mention AUDIO SYNCHRONY which makes the picture profoundly realistic. Children have asked to see the pet dog and tried to pet it through the phone!
galt
Recent INSM News
- Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 • PR Newswire (US) • 10/17/2024 12:00:00 PM
- New Subgroup Analyses from Landmark Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis Demonstrate Consistency with Positive Overall Trial Population Results • PR Newswire (US) • 10/08/2024 08:05:00 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 10/04/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 08:47:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 08:46:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2024 08:28:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 11:49:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 08:14:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/10/2024 08:06:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2024 08:19:01 PM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 09/06/2024 12:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/03/2024 09:22:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:10:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2024 07:57:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:28:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:26:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 08:05:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/12/2024 08:01:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 09:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:00:26 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:00:05 AM
- Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 08/08/2024 11:00:00 AM
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • PR Newswire (US) • 08/02/2024 12:00:00 PM
- Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024 • PR Newswire (US) • 07/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 09:19:37 PM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM